Biotech · Private company
ReNeuron Limited
Track this companyFree. Adds ReNeuron Limited to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CTX0E03 Drug Product and delivery devicePhase 2 · Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- hRPCPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Non Interventional long term safety follow upIschemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III StudyENROLLING_BY_INVITATION · started Nov 1, 2022ClinicalTrials.gov NCT05598775 · fetched Nov 12, 2026
- Investigation of Neural Stem Cells in Ischemic StrokePHASE2 · TERMINATED · started Aug 31, 2018ClinicalTrials.gov NCT03629275 · fetched Nov 12, 2026
- Safety and Tolerability of hRPC in Retinitis PigmentosaPHASE1_PHASE2 · UNKNOWN · started Dec 1, 2015ClinicalTrials.gov NCT02464436 · fetched Nov 12, 2026